Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deepak Voora

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|May 19, 2004
Use of pharmacogenetics to guide warfarin therapyDeepak Voora, Howard L McLeod, Charles Eby, et al.
Pharmacogenomics and Personalized Medicine|July 22, 2021
Independent Community Pharmacists' Experience in Offering Pharmacogenetic TestingSusanne B Haga, Rachel Mills, Jivan Moaddeb, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 2, 2022
Cost-effectiveness of CYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromesOlivia M Dong, Kevin A Friede, Catherine Chanfreau-Coffinier, et al.
Pharmacogenomics and Personalized Medicine|July 19, 2021
Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy SettingSusanne B Haga, Rachel Mills, Jivan Moaddeb, et al.
BMC Medical Genomics|January 14, 2018
Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular eventsJames A Wingrove, Karen Fitch, Brian Rhees, et al.
Plos One|November 25, 2020
Modeling statin myopathy in a human skeletal muscle microphysiological systemAnandita Ananthakumar, Yiling Liu, Cristina E Fernandez, et al.
Urogynecology (Philadelphia, Pa.)|March 19, 2025
Can Pharmacogenetics Be Used to Predict the Response to Fesoterodine Fumarate?Jennifer M Wu, Nazema Y Siddiqui, Tim Wiltshire, et al.
Clinical Pharmacology and Therapeutics|May 22, 2024
Association of Pharmacogenomic Phenotypes in CYP2D6, CYP2C9, CYP2C19, and CYP3A5 on Polypharmacy in VeteransLinas Krulikas, Jill Bates, Catherine Chanfreau, et al.
Plos One|November 21, 2017
An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health SystemJoseph E Lucas, Taylor C Bazemore, Celan Alo, et al.
Pharmacogenomics|April 21, 2020
Understanding the state of pharmacogenomic testing for thiopurine methyltransferase within a large health systemAdam Root, Randall Johnson, Ann McGee, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Drugs of Today (Barcelona, Spain : 1998)|May 19, 2004
Use of pharmacogenetics to guide warfarin therapyDeepak Voora, Howard L McLeod, Charles Eby, et al.
Pharmacogenomics and Personalized Medicine|July 22, 2021
Independent Community Pharmacists' Experience in Offering Pharmacogenetic TestingSusanne B Haga, Rachel Mills, Jivan Moaddeb, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 2, 2022
Cost-effectiveness of CYP2C19-guided P2Y12 inhibitors in Veterans undergoing percutaneous coronary intervention for acute coronary syndromesOlivia M Dong, Kevin A Friede, Catherine Chanfreau-Coffinier, et al.
Pharmacogenomics and Personalized Medicine|July 19, 2021
Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy SettingSusanne B Haga, Rachel Mills, Jivan Moaddeb, et al.
BMC Medical Genomics|January 14, 2018
Peripheral blood gene expression signatures which reflect smoking and aspirin exposure are associated with cardiovascular eventsJames A Wingrove, Karen Fitch, Brian Rhees, et al.
Plos One|November 25, 2020
Modeling statin myopathy in a human skeletal muscle microphysiological systemAnandita Ananthakumar, Yiling Liu, Cristina E Fernandez, et al.
Urogynecology (Philadelphia, Pa.)|March 19, 2025
Can Pharmacogenetics Be Used to Predict the Response to Fesoterodine Fumarate?Jennifer M Wu, Nazema Y Siddiqui, Tim Wiltshire, et al.
Clinical Pharmacology and Therapeutics|May 22, 2024
Association of Pharmacogenomic Phenotypes in CYP2D6, CYP2C9, CYP2C19, and CYP3A5 on Polypharmacy in VeteransLinas Krulikas, Jill Bates, Catherine Chanfreau, et al.
Plos One|November 21, 2017
An electronic health record based model predicts statin adherence, LDL cholesterol, and cardiovascular disease in the United States Military Health SystemJoseph E Lucas, Taylor C Bazemore, Celan Alo, et al.
Pharmacogenomics|April 21, 2020
Understanding the state of pharmacogenomic testing for thiopurine methyltransferase within a large health systemAdam Root, Randall Johnson, Ann McGee, et al.
Pageof 10